Of these studies, 6 explored the CRP in the prognosis of prostate cancer14, 15, 16, 17, 18, 19, 27 of renal cell carcinoma20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46 and 11 of urothelial carcinoma originating from bladder (n = 6) and upper urinary tract (n = 5)47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57. Here, CRP is linked to urothelial carcinoma.